Level Zero Health
San Francisco, United States· Est. 2020
Utilizing cutting-edge DNA-Based sensors to provide real-time monitoring of hormone levels in the interstitial fluid, a minimally invasive method unlocking access to hormonal data.
Private Company
Funding information not available
About
Utilizing cutting-edge DNA-Based sensors to provide real-time monitoring of hormone levels in the interstitial fluid, a minimally invasive method unlocking access to hormonal data.
Digital HealthAI / Machine Learning